BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8516549)

  • 1. [IgD myeloma: an aggressive variant. Description of a clinical case and review of the literature].
    Airoldi M; Pelucco L; Lamperti R; Gioia F
    Recenti Prog Med; 1993 Jun; 84(6):423-7. PubMed ID: 8516549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
    Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
    Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rare clinical forms of multiple myeloma].
    Golenkov AK
    Ter Arkh; 1994; 66(12):90-2. PubMed ID: 7900059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoglobulin D lambda multiple myeloma: a case report].
    Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
    Chepovetsky J; Chari A; Jagannath S; Ramanthan L
    Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
    Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
    Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
    Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
    Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of multiple myeloma: relation to class and type M component.
    Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):896-7. PubMed ID: 817790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple myeloma with D immunoglobulin].
    Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
    Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgD paraproteinemias.
    Tichý M; Matĕja F; Urban P; Matuska M
    Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
    Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A further case of IgD myeloma (author's transl)].
    Daunizeau A; Daunizeau A; Comyn F
    Sem Hop; 1979 Dec 8-15; 55(41-42):1941-3. PubMed ID: 231320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgD myeloma: immunology and ultrastructure.
    Ioachim NJ; McKenna PJ; Halperin I; Chung FJ
    Ann Clin Lab Sci; 1978; 8(3):209-18. PubMed ID: 418730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IgD/kappa myeloma].
    Golenkov AK; German GP; Zlatkina AR; Chernokhvostova EV; Cheredeev AN
    Ter Arkh; 1984; 56(11):129-31. PubMed ID: 6441298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
    Pruzanski W; Rother I
    Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
    Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
    Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term complete remission in IgD-myeloma.
    Bemelmans RH; van Toorn DW; van Leeuwen L; Schaar CG
    Eur J Haematol; 2006 Apr; 76(4):339-41. PubMed ID: 16519706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.